Jasper Therapeutics Inc. (JSPR)

6.04

0.11 (1.85%)

At close: Mar 03, 2025, 12:23 PM

Jasper Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	-71.27M	-64.47M	-37.69M	-30.64M	-31.67M	-4.99M
Depreciation & Amortization	1.37M	1.11M	975K	377K	21K	n/a
Stock-Based Compensation	6.62M	5.21M	4.09M	1.05M	1.21M	6K
Other Working Capital	n/a	2.06M	1.5M	-1.32M	938K	1.39M
Other Non-Cash Items	675K	976K	-12.59M	-9.09M	10.9M	1.62M
Deferred Income Tax	n/a	n/a	n/a	3M	-21K	n/a
Change in Working Capital	n/a	5.1M	-649K	1.62M	1.3M	1.39M
Operating Cash Flow	-62.6M	-52.07M	-45.86M	-33.68M	-18.27M	-1.97M
Capital Expenditures	-552K	-267K	-576K	-2.43M	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	20K	n/a	n/a	n/a	198.34K	n/a
Investing Cash Flow	-532K	-267K	-576K	-2.43M	198.34K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	1.5M
Common Stock Repurchased	360K	n/a	28K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	47.88M	-56K	55K	100.97M	11.29M	27.63M
Financial Cash Flow	47.88M	100.97M	55K	100.97M	11.29M	29.13M
Net Cash Flow	-15.25M	48.64M	-46.38M	64.86M	-6.98M	27.16M
Free Cash Flow	-63.15M	-52.33M	-46.43M	-36.11M	-18.27M	-1.97M